- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05054491
Ethiopia Group Antenatal Care Study at the Health Post Level (ARC004)
April 1, 2024 updated by: Jhpiego
Evaluation of the Feasibility, Acceptability and Impact of Group-based Antenatal Care at the Health Post Level on Continuation in Antenatal Care and Facility-based Delivery in Amhara, Ethiopia Using a Cluster Randomized Step-wedge Design
The purpose of this study is to determine the acceptability, feasibility, and effectiveness of a group antenatal care (G-ANC) model introduced at the health post level compared to usual antenatal care (ANC) among women who report intention to receive ANC at the health post level.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
540
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Mecha Woreda, West Gojam Zone, Amhara Region
-
Mecha, North Mecha Woreda, West Gojam Zone, Amhara Region, Ethiopia
- Enashenifalen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 49 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Minimum age of 15 years at the time of enrollment; pregnant 15-17 year-olds will be treated as emancipated/mature as per local regulations
- Gestational age less than or equal to 20 weeks at the time of enrollment determined by last menstrual period (LMP), pelvic exam, fundal height, quickening, ultrasound, and/or timing of fetal heart tones and pregnancy test
- Pregnant women able and willing to provide adequate locator information
- Planning to reside at their current location for at least 10 months
- Agree to participate in the study and continue ANC at health post
- Willing to participate and consent to follow up for up to 6 weeks post-delivery
- Are willing to receive group antenatal care at the health post level (during the intervention period)
Exclusion Criteria:
- Women who plan to travel away from the study site for more than four consecutive weeks during ANC or after 6 weeks post-delivery
- Women who are unable provide consent
- Women who have any condition that in the opinion of the investigator or designee, would complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group ANC
Intervention period in stepped wedge design where women are receiving antenatal care in a group setting
|
Group ANC is an integrated approach that incorporates physical assessment, education and skill development, and peer support and takes a broader, more holistic, woman-centered approach to traditional antenatal care
|
|
No Intervention: Individual ANC (routine)
Pre-intervention time period (control period) where the intervention is not being implemented yet (women are receiving individual antenatal care as is currently offered)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of G-ANC at the health post level
Time Frame: Less than or equal to 20 weeks gestation at enrollment into study up to 6 weeks after delivery
|
Satisfaction survey to understand satisfaction with G-ANC
|
Less than or equal to 20 weeks gestation at enrollment into study up to 6 weeks after delivery
|
|
Feasibility of G-ANC at the health post level
Time Frame: Less than or equal to 20 weeks gestation at enrollment into study up to 6 weeks after delivery
|
Documentation of number of G-ANC sessions facilitated by by health extension workers to measure feasibility
|
Less than or equal to 20 weeks gestation at enrollment into study up to 6 weeks after delivery
|
|
Effectiveness of G-ANC on continuation of ANC
Time Frame: Less than or equal to 20 weeks gestation at enrollment into study up to 6 weeks after delivery
|
Survey of self-reported number of ANC visits to document effectiveness of continuing ANC
|
Less than or equal to 20 weeks gestation at enrollment into study up to 6 weeks after delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effectiveness of G-ANC on quality of care
Time Frame: Less than or equal to 20 weeks gestation at enrollment into study up to 6 weeks after delivery
|
Survey of self-reported quality of care elements received during ANC to understand role of G-ANC on improving elements of quality of care during ANC
|
Less than or equal to 20 weeks gestation at enrollment into study up to 6 weeks after delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2021
Primary Completion (Actual)
February 28, 2024
Study Completion (Actual)
February 28, 2024
Study Registration Dates
First Submitted
August 11, 2021
First Submitted That Met QC Criteria
September 14, 2021
First Posted (Actual)
September 23, 2021
Study Record Updates
Last Update Posted (Actual)
April 2, 2024
Last Update Submitted That Met QC Criteria
April 1, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 14448
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified data will be shared with the Gates ARC partner, RTI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antenatal Care
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Peking University Third HospitalPeking University; Peking University China Center for Health Development StudiesEnrolling by invitation
-
Karolinska InstitutetUppsala University; Dalarna University; La Trobe UniversityTerminated
-
Heidelberg UniversityKarolinska Institutet; University Ghent; Centre de Recherche en Sante de Nouna... and other collaboratorsUnknownAntenatal Care and DeliveryGermany
-
Bridge to Health Medical and DentalKigezi Healthcare FoundationCompletedMaternal Health | Antenatal Care
-
Swiss Tropical & Public Health InstituteSwiss National Science Foundation; Centre Suisse de Recherches Scientifiques...RecruitingUptake of Antenatal Health Care ServicesCôte d’Ivoire
-
Population Services InternationalActive, not recruitingAntenatal Care | Postpartum Family Planning | Pre-conceptual Care | Adolescent Maternal HealthKenya
-
Hunter and New England HealthActive, not recruitingAntenatal Care and Delivery | Preventive BehaviorsAustralia
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingRetention in Care | Neonatal Morbidity | Maternal Morbidity | Prenatal Care | Antenatal HealthUnited States
Clinical Trials on Group Antenatal Care
-
Centers for Disease Control and PreventionJhpiego; Ministry of Health, TanzaniaTerminatedMalaria | Malaria in PregnancyTanzania
-
PossibleBrigham and Women's HospitalCompleted
-
Karolinska InstitutetUppsala University; Dalarna University; La Trobe UniversityTerminated
-
University of Illinois at ChicagoCompleted
-
Showa UniversityIndonesia UniversityUnknownPregnant Women | Preterm Delivery | Antenatal Care ModelIndonesia
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR); University of MalawiCompleted
-
Peking University Third HospitalPeking University; Peking University China Center for Health Development StudiesEnrolling by invitation
-
Cairo UniversityUnknown
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompleted
-
Foundation for Professional Development (Pty) LtdNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedHIV/AIDS | Pregnancy | Cost-effectiveness | Antenatal Care | Chlamydia Trachomatis | Vaginal Microbiome | Birth Outcomes | Sexually Transmitted Infection | Neisseria Gonorrhoeae | Trichomonas VaginalisSouth Africa